Swati Palit Deb

1.8k total citations
39 papers, 1.5k citations indexed

About

Swati Palit Deb is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Swati Palit Deb has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 23 papers in Molecular Biology and 12 papers in Biotechnology. Recurrent topics in Swati Palit Deb's work include Cancer-related Molecular Pathways (34 papers), Epigenetics and DNA Methylation (14 papers) and Cancer Research and Treatments (12 papers). Swati Palit Deb is often cited by papers focused on Cancer-related Molecular Pathways (34 papers), Epigenetics and DNA Methylation (14 papers) and Cancer Research and Treatments (12 papers). Swati Palit Deb collaborates with scholars based in United States, France and Finland. Swati Palit Deb's co-authors include Sumitra Deb, Mariano J. Scian, Doris Brown, Catherine A. Vaughan, Katherine E. Stagliano, W. Andrew Yeudall, Sajida Hassan, Shilpa Singh, Brad E. Windle and Michael V. Viola and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Swati Palit Deb

39 papers receiving 1.4k citations

Peers

Countries citing papers authored by Swati Palit Deb

Since Specialization

Citations

This map shows the geographic impact of Swati Palit Deb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swati Palit Deb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swati Palit Deb more than expected).

Fields of papers citing papers by Swati Palit Deb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swati Palit Deb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swati Palit Deb. The network helps show where Swati Palit Deb may publish in the future.

Co-authorship network of co-authors of Swati Palit Deb

This figure shows the co-authorship network connecting the top 25 collaborators of Swati Palit Deb. A scholar is included among the top collaborators of Swati Palit Deb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swati Palit Deb. Swati Palit Deb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oncogenic Mutant p53 Sensitizes Non–Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress–Dependent Induction of Mitochondrial Apoptosis 2024 ·Cancer Research Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jennifer E. Koblinski, (unknown), Swati Palit Deb, (unknown), Jorge J. Nieva, Senthil K. Radhakrishnan, Hisashi Harada, Steven R. Grossman	3
2	The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3 2021 ·Nature Communications ·Catherine A. Vaughan, Shilpa Singh, Mark A. Subler, Jolene J. Windle, Kazushi Inoue, Elizabeth A. Fry, (unknown), Steven R. Grossman, Brad E. Windle, W. Andrew Yeudall, Swati Palit Deb, Sumitra Deb	18
3	Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells 2017 ·Molecular Oncology ·Catherine A. Vaughan, Shilpa Singh, Steven R. Grossman, Brad E. Windle, Swati Palit Deb, Sumitra Deb, (unknown), (unknown)	14
4	Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination 2016 ·Molecular Cancer Research ·(unknown), Ian M. Love, Priyadarshan K. Damle, Nitai D. Mukhopadhyay, Swati Palit Deb, Sumitra Deb, Steven R. Grossman	14
5	Lung Cancer Stem Cells, p53 Mutations and MDM2 2014 ·Sub-cellular biochemistry ·(unknown), Swati Palit Deb, Sumitra Deb, Raj R. Rao	20
6	p53: Its Mutations and Their Impact on Transcription 2014 ·Sub-cellular biochemistry ·Catherine A. Vaughan, Isabella Pearsall, W. Andrew Yeudall, Swati Palit Deb, Sumitra Deb	29
7	Allele specific gain-of-function activity of p53 mutants in lung cancer cells 2012 ·Biochemical and Biophysical Research Communications ·Catherine A. Vaughan, (unknown), Isabella Pearsall, Shilpa Singh, Brad E. Windle, W. Andrew Yeudall, Swati Palit Deb, Sumitra Deb, (unknown), (unknown)	20
8	Measurement of Chemosensitivity and Growth Rate in p53 Expressing Cells 2012 ·Methods in molecular biology ·Mahesh Ramamoorthy, Catherine A. Vaughan, Sumitra Deb, Swati Palit Deb	1
9	Use of the DNA Fiber Spreading Technique to Detect the Effects of Mutant p53 on DNA Replication 2012 ·Methods in molecular biology ·(unknown), Sumitra Deb, Swati Palit Deb	12
10	Human Oncoprotein MDM2 Up-regulates Expression of NF- B2 Precursor p100 Conferring a Survival Advantage to Lung Cells 2011 ·Genes & Cancer ·Catherine A. Vaughan, Lathika Mohanraj, Sandeep K. Singh, Catherine I. Dumur, Mahesh Ramamoorthy, Carleton T. Garrett, B E Windle, W. Andrew Yeudall, Sumitra Deb, Swati Palit Deb	13
11	Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration 2011 ·Carcinogenesis ·W. Andrew Yeudall, Catherine A. Vaughan, Hiroshi Miyazaki, Mahesh Ramamoorthy, (unknown), Christopher G. Chapman, Hui‐Xin Wang, (unknown), Anna Bulysheva, Swati Palit Deb, Brad E. Windle, Sumitra Deb	103
12	MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle 2009 ·Molecular Cancer Research ·(unknown), Mahesh Ramamoorthy, Lathika Mohanraj, Sumitra Deb, Swati Palit Deb	21
13	Tumor-Derived p53 Mutants Induce NF-κB2 Gene Expression 2005 ·Molecular and Cellular Biology ·Mariano J. Scian, Katherine E. Stagliano, Michelle A. E. Anderson, Sajida Hassan, (unknown), (unknown), Swati Palit Deb, Sumitra Deb, (unknown), (unknown)	131
14	Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes 2004 ·Oncogene ·Mariano J. Scian, Katherine E. Stagliano, (unknown), (unknown), Evie H. Carchman, Anindita Das, Kristoffer Valerie, Swati Palit Deb, Sumitra Deb	102
15	Flow Cytometric Analysis of MDM2-Mediated Growth Arrest 2003 ·Humana Press eBooks ·(unknown), Swati Palit Deb	8
16	Transactivation and Transrepression Studies with p53 2003 ·Humana Press eBooks ·Mariano J. Scian, (unknown), Swati Palit Deb, Sumitra Deb	2
17	Hetero-oligomerization does not compromise ‘gain of function’ of tumor-derived p53 mutants 2002 ·Oncogene ·(unknown), Mariano J. Scian, (unknown), Wěi Li, (unknown), Abhay Sankar Chakraborti, Swati Palit Deb, Sumitra Deb	23
18	The human oncoprotein MDM2 uses distinct strategies to inhibit transcriptional activation mediated by the wild-type p53 and its tumor-derived mutants 2001 ·International Journal of Oncology ·Doris Brown, (unknown), (unknown), (unknown), Rubén M. Muñoz, Sumitra Deb, Swati Palit Deb	8
19	Transcriptional Activation of the Human Epidermal Growth Factor Receptor Promoter by Human p53 1996 ·Molecular and Cellular Biology ·John Ludes-Meyers, Mark A. Subler, (unknown), Rubén M. Muñoz, (unknown), John E. Bigger, Doris Brown, Swati Palit Deb, Sumitra Deb	152
20	Wild-Type Human p53 Transactivates the Human Proliferating Cell Nuclear Antigen Promoter 1995 ·Molecular and Cellular Biology ·(unknown), Doris Brown, Sumitra Deb, Swati Palit Deb, (unknown), (unknown)	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact